# Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women

> **NCT03837015** · PHASE1 · COMPLETED · sponsor: **McMaster University** · enrollment: 50 (actual)

## Conditions studied

- HIV-1-infection
- Bacterial Vaginoses

## Interventions

- **DRUG:** Estring Vaginal Ring
- **OTHER:** RepHresh Pro-B

## Key facts

- **NCT ID:** NCT03837015
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03837015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03837015, "Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03837015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
